Boston Scientific makes IVL play with Bolt Medical acquisition – MassDevice

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer Bolt Medical.

Do you trust this headline?

Based on recent headline ratings, 90% of this readership currently trusts the local media, which has an average score of 80% regionally and is currently trending positive.

90%

Media Trust Score